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Page 2 of 7 Depression and anxiety are more common in patients with cancer, and they are associated with poorer quality of life and cancer survival. This article offers advice on how to recognise these disorders, and when to offer referral for specialist advice.
During the assessment, form an impression about whether the patient has depression:  Is this pathological low mood or anxiety, or is this a normal response to the threat posed by cancer?  Could this be a direct effect of a medication or the disease?
What you should cover History
Explore current mood, and difficulties with sleep. Facilitate disclosure by acknowledging that some patients may feel depressed or anxious after a cancer diagnosis, even when receiving life-saving treatment.
Ask about:
• Specific psychological symptoms: Psychological symptoms are the key diagnostic pointers of depression in patients with cancer. Ask about anhedonia (loss of pleasure or interest in previously enjoyable activities), and pronounced symptoms of helplessness, hopelessness, guilt, and suicidal ideation causing severe distress or impairment, as these are very likely to be diagnostic of depression 5
• Does the patient feel subjectively very low in mood or report panic symptoms? Has he ever experienced this before? Specific biological symptoms: Is the problem specifically initial insomnia /early morning waking, or is sleep broken due to pain or recent high-dose steroids?? • Check that depressive symptoms are not a result of the biologically-mediated effects of the tumour or treatment (see infographic). 4 Weight loss, low energy, and poor motivation may be a consequence of cancer cachexia or chemotherapy. How are these symptoms affecting the person's life and ability to function? Are they likely to influence his cancer treatment decisions? • Current physical symptoms, including but not limited to pain and bowel habit. Is he anxious about other symptoms, fearing they represent cancer spread? For patients with high levels of anxiety, it may be hard to distinguish between an anxiety disorder, an adjustment disorder, and a transient but normal response to a lifechanging diagnosis. Anxiety is regarded as pathological where it is disproportionate to the level of threat (for example high beyond 10 days after receiving bad news), persists or deteriorates without intervention, and disrupts usual functioning.
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Previous medical history Does he have any other medical problems associated with depression? Take an alcohol history, especially as rectal cancer is associated with alcohol use. Hazardous alcohol use will worsen low mood/anxiety, and render antidepressants ineffective.
Previous psychiatric history:
Is this a further relapse of a longstanding recurrent depressive disorder or bipolar mood disorder?
Risk Assessment
There is no evidence that screening for suicidal thoughts induces suicidal ideation.
Explore suicidal thoughts, which may be passive (eg. "I don't care if I wake tomorrow or not.
I wish I was dead") or active (eg. "I am thinking of ending my life"). Ask whether the patient has begun to think of ways to end their life and whether they intend to act on this. If so, when are they planning to take action? 
Clinical examination
Whether the aetiology is thought to be biopsychosocial or due to direct biological effects (for example due to recent anti-folate chemotherapy), a full physical screen will identify any reversible contributory causes.
In this patient's case, as for any assessment for depression, this should include:
• Mental state examination, looking for signs of self-neglect, poor eye contact, depressed posture, agitation or psychomotor retardation, depressive cognitions, suicidal thoughts / planning / intent, depressive delusions. Test concentration and memory (after recent chemotherapy).
• Medical investigation should include reviewing full blood count, renal, thyroid and liver function tests. The oncologists will have ruled out bone or brain metastases as part of the pre-operative staging of the cancer.
What you should do
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Further details about management are found in the accompanying Clinical Update but the basic approach would include:
Address any underlying biological causes: for example hypothyroidism independent of his cancer. Colorectal cancers have few neuropsychiatric effects. If his low mood is thought to be an adverse effect of anti-folate chemotherapy, Vitamin B12 administration may ameliorate this by correcting raised homocysteine levels, but this remains untrialled.
Psychological approaches: group or individual cognitive-behavioural strategies to understand and cope with his depressive symptoms and wider psychological therapy approaches to explore existential issues. These may be available from a psychosocial support service embedded in local cancer services, or from local psychological therapy services such as the Improving Access to Psychological Therapies (IAPT) programme. Where specialist services are not available, Increasing Access to Psychological Therapy (IAPT) services may also have long term conditions support available to address depression and anxiety.
Pharmacological approach: assuming no alcohol misuse, Sertraline or Citalopram would usually be appropriate first-line agents, with a gastro-protective agent if he has previous gastritis (see General prescribing pointers in patients with cancer). However, these SSRIs occasionally cause diarrhoea. In his case, choice of antidepressant should anticipate forthcoming stoma, and Mirtazapine would be a better option due to its relatively neutral effect on bowel function.
Psychosocial support: local voluntary sector support groups for people with cancer, and web-based psychoeducation resources are likely to be of benefit in self-management of distress.
When to refer
Referral for specialist counselling and specific psychological interventions is indicated where depression or anxiety seriously challenge coping mechanisms or give rise to persistent distress. Such interventions include anxiety management or cognitive-behavioural therapy tailored to cancer contexts, and are provided in specialist psychological support services, including specialist counsellors and clinical psychologists embedded in cancer services.
Patients with cancer treated in primary care for major depression have better response rates to antidepressants after prescribing input from a psychiatrist. 8 Liaison psychiatrists have Item: BMJ-UK; Article ID: pita270318; Article Type: Standard article; TOC Heading: Practice; DOI: 10.1136/bmj.k1488
Page 5 of 7 particular expertise in selecting antidepressants in the context of complex medical or surgical care, particularly in the case of treatment resistance. In hospitals where there is no specialist oncology liaison service, or where liaison psychiatry input is only available for in-patients, prescribing advice for out-patients may be sought from community-based psychiatric services.
Suicidal ideation, psychotic symptoms, mania, and confusion or severe depression of rapid onset after chemotherapy or corticosteroid administration, are all indications for urgent psychiatric referral.
Box start
Desire for hastened death "Desire for hastened death" is the term used to describe suicidal thoughts, requests for assisted suicide, and requests for euthanasia in terminally ill patients. It is reported by 17% of inpatients receiving end-of-life cancer care and is associated with major depression.
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Commonly such patients report uncontrolled pain, burdensomeness, loss of dignity, and fear of a painful death. While healthcare staff might be asked to assist death at the end, this is illegal in the UK.
• If a person asks about options for hastening their death, use their request to open up a conversation about their fears about death • Explore modifiable contributory factors, particularly pain.
• Clarify that assistance to die cannot be provided, document the discussion, and explain your obligation to share their feelings with senior professional colleagues
Box end

Box start
General prescribing pointers in patients with cancer Avoid • Selective serotonin reuptake inhibitors (SSRIs) in frail elderly patients due to risk of hyponatraemia (especially in women) • Monoamine oxidase inhibitors (MAOIs) due to the potential for interactions with opioids and anaesthetics • Fluoxetine or paroxetine in patients receiving tamoxifen as they inhibit metabolism to its active metabolite. Venlafaxine or citalopram are advised instead • Mirtazapine and mianserin where white cells are compromised (due to risk of agranulocytosis), and SSRIs where platelets are compromised (due to increased risk of bleeding) • Tricyclics-particularly clomipramine, dosulepin, and high dose amitriptyline-in patients with a reduced seizure threshold. Sertraline is advised as it has a lower risk of precipitating seizures
• SSRIs in patients taking procarbazine (an MAOI), and SSRIs or serotonin and norepinephrine reuptake inhibitors (SNRIs) in patients prescribed fentanyl, tramadol, or ondansetron, due to the risk of serotonin syndrome • SSRIs in patients experiencing chemotherapy-induced nausea, due to treatment-initiation nausea • Psychotropics causing QTc prolongation (such as tricyclics, quetiapine) with ondansetron or with most molecularly targeted therapies (particularly vemurafenib)
